Should You Buy Oramed Pharmaceuticals, Inc. (ORMP) Stock Wednesday?

Oramed Pharmaceuticals, Inc. (ORMP) stock is down -56.53% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives ORMP stock a score of 34 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 27. ORMP's rank also includes a long-term technical score of 44.

ORMP has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ORMP!

See Full ORMP Report

What's Happening with ORMP Stock Today

Oramed Pharmaceuticals, Inc. (ORMP) stock is higher by 4.53% while the S&P 500 is down -1.31% as of 12:14 PM on Wednesday, Aug 2. ORMP is up $0.15 from the previous closing price of $3.31 on volume of 242,458 shares. Over the past year the S&P 500 has risen 10.40% while ORMP is down -56.53%. ORMP lost -$0.75 per share in the over the last 12 months. Click Here to get the full Stock Report for Oramed Pharmaceuticals, Inc. stock.